GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Filed Mar 31, 2011 · 10-K · 90 days after period end · 0001513160-11-000020
derived · Computed from the longer spans the company filed.
no prior Q4 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2010 · filed Mar 31, 2011 · 90 d after period end
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
